DK0692963T3 - Anvendelse af terbinafin til terapeutisk behandling af pneumocystose - Google Patents

Anvendelse af terbinafin til terapeutisk behandling af pneumocystose

Info

Publication number
DK0692963T3
DK0692963T3 DK94910517T DK94910517T DK0692963T3 DK 0692963 T3 DK0692963 T3 DK 0692963T3 DK 94910517 T DK94910517 T DK 94910517T DK 94910517 T DK94910517 T DK 94910517T DK 0692963 T3 DK0692963 T3 DK 0692963T3
Authority
DK
Denmark
Prior art keywords
terbinafine
pct
pneumocystosis
therapeutic treatment
date sep
Prior art date
Application number
DK94910517T
Other languages
English (en)
Inventor
Simone Claudio De
Carlo Contini
Sonia Tzoutzoglou
Original Assignee
Vsl Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vsl Pharma Ltd filed Critical Vsl Pharma Ltd
Application granted granted Critical
Publication of DK0692963T3 publication Critical patent/DK0692963T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94910517T 1993-03-12 1994-03-11 Anvendelse af terbinafin til terapeutisk behandling af pneumocystose DK0692963T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM930154A IT1261776B (it) 1993-03-12 1993-03-12 Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
PCT/IT1994/000023 WO1994020082A1 (en) 1993-03-12 1994-03-11 Use of terbinafine for the therapeutic treatment of pneumocystosis

Publications (1)

Publication Number Publication Date
DK0692963T3 true DK0692963T3 (da) 2002-10-14

Family

ID=11401596

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94910517T DK0692963T3 (da) 1993-03-12 1994-03-11 Anvendelse af terbinafin til terapeutisk behandling af pneumocystose

Country Status (12)

Country Link
US (1) US5719192A (da)
EP (1) EP0692963B1 (da)
JP (1) JPH08508012A (da)
KR (1) KR100343031B1 (da)
AT (1) ATE219667T1 (da)
CA (1) CA2157590C (da)
DE (1) DE69430867T2 (da)
DK (1) DK0692963T3 (da)
ES (1) ES2178650T3 (da)
IT (1) IT1261776B (da)
PT (1) PT692963E (da)
WO (1) WO1994020082A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003360D0 (en) 2000-02-14 2000-04-05 Novartis Ag Monoclonal antibodies
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
CN101829319A (zh) 2003-12-08 2010-09-15 Cpex药品公司 用于胰岛素治疗的药用组合物及方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes

Also Published As

Publication number Publication date
WO1994020082A1 (en) 1994-09-15
IT1261776B (it) 1996-06-03
DE69430867D1 (de) 2002-08-01
ITRM930154A0 (it) 1993-03-12
CA2157590A1 (en) 1994-09-15
CA2157590C (en) 2006-01-10
JPH08508012A (ja) 1996-08-27
EP0692963A1 (en) 1996-01-24
US5719192A (en) 1998-02-17
DE69430867T2 (de) 2003-01-02
ES2178650T3 (es) 2003-01-01
KR100343031B1 (ko) 2002-11-07
EP0692963B1 (en) 2002-06-26
ITRM930154A1 (it) 1994-09-12
KR960700699A (ko) 1996-02-24
PT692963E (pt) 2002-10-31
ATE219667T1 (de) 2002-07-15

Similar Documents

Publication Publication Date Title
MXPA04004364A (es) Composiciones para el tratamiento de disfuncion sexual femenina postmenopausica.
HUP0100437A2 (hu) Szabályzott felszabadulású gyógyszerkészítmény tolterodin adagolására
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
DE69110678D1 (de) Prophylaktische und therapeutische anwendungen von peroxidasen.
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
MX9708582A (es) Compuesto alquileter y pirimidina-tioalquilo alfa-substituidos.
HUP0102728A2 (hu) Módszerek és transzdermális készítmények fájdalom csillapítására
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
HUP0400548A2 (hu) Belső szemnyomást csökkentő hatóanyag-kombinációk alkalmazása glaukoma kezelésére szolgáló gyógyszerkészítmények előállítására
ITMI922331A1 (it) Uso di paratormone, suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
KR970061244A (ko) 치매 치료용 약학 조성물
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
DK0692963T3 (da) Anvendelse af terbinafin til terapeutisk behandling af pneumocystose
GEP20032969B (en) Sertraline Oral Concentrate
EE9700366A (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
MX2024001230A (es) Anticoncepcion oral con progestageno solo.
PE20011042A1 (es) Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan
DE60210804D1 (de) Verwendung von propionyl-l-carnitin oder dessen pharmakologisch akzeptabler salze zur herstellung eines medikamentes zur behandlung von la peyronie's krankheit
UA30722A (uk) Спосіб профілактики гнійно-септичних ускладнень у породіль
UA79424C2 (en) Use of fsh for treatment of infertility in women